We’re an award-winning, patient-centered biotechnology company focused on using the body’s own microorganisms to prevent and treat debilitating infections and diseases.
Employees: 11-50
Total raised: $57.74M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Investing ... | investingw... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 05.04.2024 | - | $34.22M | - |
| 07.09.2021 | Series A | $21M | - |
| 29.05.2019 | Seed | $2.53M | - |
Mentions in press and media 11
| Date | Title | Description |
| 07.05.2024 | DIGIT Deal Roundup | April 2024 | Welcome to the latest edition of the DIGIT Deal Roundup. As we enter Spring, Scotland’s tech sector is seeing some big funding wins in medtech, the energy sector, and the broader innovation economy. For a recap on those standout stories, he... |
| 06.04.2024 | EnteroBiotix: Pioneering Microbial Therapeutics | EnteroBiotix, a Glasgow-based biotech company, secures a hefty £27M funding round to advance its cutting-edge microbial therapeutics. The funding, a mix of fresh equity and converted loan notes, comes from a consortium of investors, includi... |
| 05.04.2024 | Scotland’s EnteroBiotix closes €31.4M funding round to advance its clinical-stage microbial therapeutics | Read this article in: EnteroBiotix, a Glasgow-based biotech firm specialising in full-spectrum microbiome therapeutics, announced that it has closed a funding round totalling £27M (approximately €31.46M). EnteroBiotix’s financing includes £... |
| 04.04.2024 | EnteroBiotix Closes £27M Financing Round | EnteroBiotix, a Glasgow, Scotland, UK-based clinical-stage biotechnology company, raised £27M in funding. The financing, which comprises £15.7m of new equity and the conversion of £11.6m of loan notes into equity came from Thairm Bio and Ki... |
| 04.04.2024 | Glasgow Biotech Company EnteroBiotix Lands £27M Funding Round | This substantial financial boost, backed by both new and existing investors, marks a significant milestone for the company as it looks to improve the landscape of microbiome therapeutics. The funding round was made up of £15.7m in equity fu... |
| 07.09.2021 | EnteroBiotix Raises $21M in Series A Funding | EnteroBiotix, a Glasgow, Scotland-based biopharmaceutical company, raised $21m in Series A funding. The round was led by Thairm Bio with participation from Kineticos Ventures, Scottish Enterprise and SIS Ventures. The company intends to use... |
| 29.05.2019 | Aberdeen biopharmaceutical startup EnteroBiotix raises £2m seed extension investment | The Scottish biopharmaceutical startup EnteroBiotix has announced the closing of a £2m seed extension investment. The oversubscribed round was led by Scottish angel firm Equity Gap and supported by existing investors the Scottish Investment... |
| 29.05.2019 | EnteroBiotix Secures £2m Seed Extension Investment | ABERDEEN, Scotland & CAMBRIDGE, Mass.--(BUSINESS WIRE)--EnteroBiotix, a leading clinical stage microbiome therapeutics company headquartered in Aberdeen, Scotland, has closed an oversubscribed seed extension investment and is set for in... |
| 29.05.2019 | EnteroBiotix Secures Additional £2m in Seed Funding | EnteroBiotix, an Aberdeen, Scotland, UK-based clinical stage microbiome therapeutics company, raised £2m in additional seed funding. The round was led by Equity Gap with participation from the Scottish Investment Bank (the investment arm of... |
| 02.10.2018 | DIGIT Movers and Shakers September 2018 | Recruitment LendingCrowd Sir Sandy Crombie, former CEO of Standard Life and senior independent director at Royal Bank of Scotland, has joined the LendingCrowd as chairman. Commenting on the announcement, he said: “LendingCrowd has made impr... |
Show more